Pulmonary Nuclear protein in Testis (NUT) carcinoma: clinical, molecular characteristics, and treatment strategies
Advanced molecular techniques are critical for diagnosing pulmonary NUT carcinoma, but survival outcomes remain poor. Surgical resection with adjuvant therapy offers better outcomes for early-stage patients, while chemotherapy and immunotherapy show limited efficacy in metastatic cases due to the tumor's aggressive behavior. Early detection and innovative therapies are essential for improving outcomes.
Authors
- Jingjing Qu (ORCID: https://orcid.org/0000-0002-8079-4722)
- Yan‐Ping Zhu
- Zhen Chen (ORCID: https://orcid.org/0000-0001-6789-6188)
- Qian Shen (ORCID: https://orcid.org/0000-0002-4097-6775)
- Jinyan Huang (ORCID: https://orcid.org/0000-0002-8053-0209)
Institutions
- Zhejiang Medicine (China) (CN)
- First Affiliated Hospital Zhejiang University (CN)
- Zhejiang University (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-02-04
- DOI
- https://doi.org/10.1186/s12885-025-13593-3
- Primary Topic
- Protein Degradation and Inhibitors
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Natural Science Foundation of Zhejiang Province